FINWIRES · TerminalLIVE
FINWIRES

Corporate Earnings, Easing Oil Prices Lift European Bourses Midday

By

-- European bourses tracked moderately higher midday Tuesday as oil prices eased and as the continental earnings season continued to pour in.

Tech and energy stocks led gains on continental trading floors.

UniCredit shares rose 5.6% mid-session after the company reported strong Q1 profits.

Front-month North Sea Brent crude-oil futures were down 1% at $113.28 a barrel.

Investors also eyed Wall Street futures in the green amid mixed closes overnight on Asian exchanges.

In economic news, the European Union and Japan agreed to expand cooperation across data, digital identity, AI, quantum, infrastructure, standardization, and online platform issues, the EU-Japan Digital Partnership Council reported.

The pan-continental Stoxx Europe 600 Index was up 0.5% mid-session.

The Stoxx Europe 600 Technology Index was up 1.6%, and the Stoxx 600 Banks Index gained 0.1%.

The Stoxx Europe 600 Oil and Gas Index rose 0.7%, while the Stoxx 600 Europe Food and Beverage Index edged 0.6% higher.

The REITE, a European REIT index, gained 0.2%.

On the national market indexes, Germany's DAX was up 1.3%, but the FTSE 100 in London lost 1.3%. The CAC 40 in Paris was up 0.6%, and Spain's IBEX 35 advanced 1.5%.

Yields on benchmark 10-year German bonds were higher, near 3.1%.

The Euro Stoxx 50 volatility index was down 3.3% at 24.08, but still indicating above-average volatility for European stock markets in the next 30 days, a negative signal. A reading above 20 indicates choppier markets ahead, while below 20 suggests calmer exchanges.

Related Articles

Mining & Metals

Troilus Mining Upsizes Debt Financing Mandate for up to US$1.2 Billion

Troilus Mining (TLG.TO) increased its previously announced debt financing mandate from up to US$1.0 billion to up to US$1.2 billion.The upsizing reflects "continued strong lender support and advancing progress toward a fully funded construction package for the Troilus copper-gold project, located in north-central Quebec, Canada," it said.The financing is being led by a syndicate of leading global financial institutions, including Societe Generale, KfW IPEX-Bank, and Export Development Canada, and is expected to form the cornerstone of the project's overall financing structure, the company added.Shares of the company closed down 1.2% to $1.59 on Monday on the Toronto Stock Exchange.

$TLG.TO
Australia

IPG Photonics' Q1 Adjusted Earnings Decline, Revenue Increases; Q2 Outlook Issued; Shares Drop Pre-Bell

IPG Photonics (IPGP) reported Q1 adjusted earnings Tuesday of $0.29 per diluted share, down from $0.31 a year earlier.An analyst polled by FactSet expected $0.31.Revenue for the quarter ended March 31 was $265.5 million, compared with $227.8 million a year earlier.An analyst polled by FactSet expected $265.5 million.The company expects Q2 adjusted EPS of $0.25 to $0.55 and $260 million to $290 million in revenue. Analysts polled by FactSet expect $0.44 in adjusted EPS on revenue of $275.7 million.Separately, IPG Photonics said it agreed on a global settlement with TRUMPF Laser- und Systemtechnik to resolve and close their patent dispute. No other details were disclosed.Shares of IPG Photonics were down more than 17% premarket Tuesday.Price: $100.60, Change: $-21.73, Percent Change: -17.76%

$IPGP
Research

Research Alert: Idexx Posts Solid Q1 Fueled By Innovation And Strong Cag Group Performance

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:IDEXX posted strong Q1 results with EPS of $3.47 (+17% Y/Y), beating expectations by $0.06, while revenue reached $1.141B (+14% Y/Y), $30M above consensus. CAG Diagnostics recurring revenue grew 14% Y/Y to $920M, demonstrating resilient demand for core diagnostic solutions. Operating margin expanded 10 bps to 31.8%, supported by strong recurring revenue gains and operational productivity initiatives. International markets showed particular strength with CAG revenue growing 22.7% compared to 11% domestically, highlighting successful global expansion efforts, in our view. The 12% expansion in the global premium instrument installed base and 20% growth in VetLab consumables underscore continued innovation adoption. Management raised the full-year 2026 guidance, reflecting confidence in the business trajectory, in our view: IDXX sees 2026 sales in the range of $4.675B-4.760B vs. prior $4.632B-$4.720B, representing +8.6%-10.6% Y/Y growth and EPS of $14.45-$14.90 vs. prior $14.29-$14.80, reflecting +11%-14% Y/Y.

$IDXX